Nanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges

Figure 2

A schematic representation of the EPR effect. The leaky vasculature and dysfunctional lymphatics of solid tumors allow the preferential accumulation and retention of colloidal nanoparticles in contrast to the tight vasculature of normal tissue, which excludes nanoparticles.